Friday, May 9, 2025
Latest:
  • Bake Off desserts are a recipe for success when it comes to health benefits
  • Benidipine calcium channel blocker improves cigarette smoke-induced lung emphysema: Study
  • WHO declares JN.1 a COVID variant of interest as it spreads widely
  • thioridazine action
  • New insight on how neural dynamics vary during spontaneous behavior

Erwotex.net

  • Health News
  • Beauty & Balance
  • Wellness
  • Online

Home ยป Pharmaceuticals (NEC) (TRBC level 5)

Health News 

Novartis closes U.S. gene therapy site as Zolgensma sales fell from Q3 to Q4

28/03/2021 closure, Company News, Europe:, Job Cuts, NOVARTIS, Pharmaceuticals (NEC) (TRBC level 5), Pharmaceuticals & Medical Research (TRBC level 2), plant, Switzerland, US, ZOLGENSMA

FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the French company’s headquarters in Rueil-Malmaison near Paris, France,

Read more
Health News 

Pfizer says South African variant could significantly reduce vaccine protection

17/02/2021 Bio Therapeutic Drugs (TRBC level 5), Biotechnology & Medical Research (NEC) (TRBC level 5), Biotechnology & Medical Research (TRBC level 4), Company News, coronavirus, epidemics, Europe:, Germany, health, Healthcare (TRBC level 1), Life Sciences, Major News, Pharmaceuticals (NEC) (TRBC level 5), Pharmaceuticals & Medical Research (TRBC level 2), Public Health, science, US, vaccines, variants

(Reuters) – A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the

Read more
Recent Posts
  • Bake Off desserts are a recipe for success when it comes to health benefits
  • Benidipine calcium channel blocker improves cigarette smoke-induced lung emphysema: Study
  • WHO declares JN.1 a COVID variant of interest as it spreads widely
  • thioridazine action
  • New insight on how neural dynamics vary during spontaneous behavior
Copyright © 2025 Erwotex.net. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok